What is the Johnson&Johnson Patient Assistance Foundation?
Johnson & Johnson Patient Assistance Foundation, Inc. The Johnson & Johnson Patient Assistance Foundation, Inc. (JJPAF) is a nonprofit organization that assists U.S. patients without adequate financial resources and prescription coverage in obtaining free products donated by the operating companies of Johnson & Johnson.
How do I apply for a patient assistance program?
PATIENT To apply for assistance all information must be complete and include the following steps: Complete pages 1 and 2 and sign the Patient Declaration and Authorization to Share information on page 2 Ask your Healthcare Professional (HCP) to complete pages 3-4 and sign page 4 Include a copy of your most recent 1040 or 1040EZ federal tax return
What is jjpaf and how do I apply?
JJPAF is an independent organization that reflects the long-standing commitment of the Johnson & Johnson operating companies to help patients access prescription medicines. Please visit the JJPAF website for more information regarding eligibility.
How do I complete the patient declaration and authorization to share information?
Complete pages 1 and 2 and sign the Patient Declaration and Authorization to Share information on page 2 Ask your Healthcare Professional (HCP) to complete pages 3-4 and sign page 4 Include a copy of your most recent 1040 or 1040EZ federal tax return.
See more
How to fill out and sign ophthalmi online?
Get your online template and fill it in using progressive features. Enjoy smart fillable fields and interactivity. Follow the simple instructions below:
Accredited Business
Guarantees that a business meets BBB accreditation standards in the US and Canada.
What is empiric antifungal therapy?
Empiric anti-fungal therapy should be considered in patients at risk for invasive fungal infections who develop severe systemic illness. Bacterial, viral, and other infections due to opportunistic pathogens, including Legionella, Listeria, and Salmonella.
Is remicde used for latent TB?
Active tuberculosis (TB), including reactivation of latent TB. Patients frequently presented with disseminated or extrapulmonary disease. Patients should be tested for latent TB before and during treatment with REMICADE®.1,2 Treatment for latent infection should be initiated prior to treatment with REMICADE®.
Is Remicade a heart failure medication?
The use of REMICADE ® at doses >5 mg/kg is contraindicated in patients with moderate or severe heart failure. REMICADE ® is contraindicated in patients with a previous severe hypersensitivity reaction to infliximab or any of the inactive ingredients of REMICADE ® or any murine proteins (severe hypersensitivity reactions have included anaphylaxis, hypotension, and serum sickness).
What is JJPAF in medicine?
JJPAF is an independent organization that reflects the long-standing commitment of the Johnson & Johnson operating companies to help patients access prescription medicines. Please visit the JJPAF website for more information regarding eligibility.
What is JJPAF?
The Johnson & Johnson Patient Assistance Foundation, Inc. (JJPAF) is a nonprofit organization that assists U.S. patients without adequate financial resources and prescription coverage in obtaining free products donated by the operating companies of Johnson & Johnson. JJPAF is an independent organization that reflects the long-standing commitment of the Johnson & Johnson operating companies to help patients access prescription medicines. Please visit the JJPAF website for more information regarding eligibility.
What is PPA in healthcare?
The Partnership for Prescription Assistance (PPA) helps qualifying U.S. patients without prescription drug coverage get the medicines they need for free or nearly free. PPA offers a single point of access to more than 475 public and private programs, including nearly 200 offered by pharmaceutical companies.